These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26373206)

  • 1. An in vitro--in silico--in vivo approach in biopharmaceutical drug characterization: metformin hydrochloride IR tablets.
    Beloica S; Cvijić S; Homšek I; Bogataj M; Parojčić J
    Pharmazie; 2015 Jul; 70(7):458-65. PubMed ID: 26373206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biowaiver approach for biopharmaceutics classification system class 3 compound metformin hydrochloride using in silico modeling.
    Crison JR; Timmins P; Keung A; Upreti VV; Boulton DW; Scheer BJ
    J Pharm Sci; 2012 May; 101(5):1773-82. PubMed ID: 22334460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets.
    Beloica S; Cvijić S; Bogataj M; Parojčić J
    Eur J Pharm Sci; 2015 Jul; 75():151-9. PubMed ID: 25861718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Justification of metformin hydrochloride biowaiver criteria based on bioequivalence study.
    Homsek I; Parojcić J; Dacević M; Petrović L; Jovanović D
    Arzneimittelforschung; 2010; 60(9):553-9. PubMed ID: 21117498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H; Löbenberg R
    Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case study on the in silico absorption simulations of levothyroxine sodium immediate-release tablets.
    Kocic I; Homsek I; Dacevic M; Grbic S; Parojcic J; Vucicevic K; Prostran M; Miljkovic B
    Biopharm Drug Dispos; 2012 Apr; 33(3):146-59. PubMed ID: 22374714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biowaiver extension potential to BCS Class III high solubility-low permeability drugs: bridging evidence for metformin immediate-release tablet.
    Cheng CL; Yu LX; Lee HL; Yang CY; Lue CS; Chou CH
    Eur J Pharm Sci; 2004 Jul; 22(4):297-304. PubMed ID: 15196586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro--in silico--in vivo drug absorption model development based on mechanistic gastrointestinal simulation and artificial neural networks: nifedipine osmotic release tablets case study.
    Ilić M; Ðuriš J; Kovačević I; Ibrić S; Parojčić J
    Eur J Pharm Sci; 2014 Oct; 62():212-8. PubMed ID: 24911992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of in vitro biorelevant dissolution and in silico PBPK model of carvedilol to predict bioequivalence of oral drug products.
    Ibarra M; Valiante C; Sopeña P; Schiavo A; Lorier M; Vázquez M; Fagiolino P
    Eur J Pharm Sci; 2018 Jun; 118():176-182. PubMed ID: 29605455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers.
    Balan G; Timmins P; Greene DS; Marathe PH
    J Pharm Sci; 2001 Aug; 90(8):1176-85. PubMed ID: 11536222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro-in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation.
    Grbic S; Parojcic J; Ibric S; Djuric Z
    AAPS PharmSciTech; 2011 Mar; 12(1):165-71. PubMed ID: 21181508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in silico approach to determine challenges in the bioavailability of ciprofloxacin, a poorly soluble weak base with borderline solubility and permeability characteristics.
    Hansmann S; Miyaji Y; Dressman J
    Eur J Pharm Biopharm; 2018 Jan; 122():186-196. PubMed ID: 29111469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro in-vivo correlation models for glibenclamide after administration of metformin/glibenclamide tablets to healthy human volunteers.
    Balan G; Timmins P; Greene DS; Marathe PH
    J Pharm Pharmacol; 2000 Jul; 52(7):831-8. PubMed ID: 10933133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical Model-Based Accelerated Development of Extended-release Metformin Hydrochloride Tablet Formulation.
    Chen W; Desai D; Good D; Crison J; Timmins P; Paruchuri S; Wang J; Ha K
    AAPS PharmSciTech; 2016 Aug; 17(4):1007-13. PubMed ID: 26729531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.